ARAF mutations confer resistance to RAF dimer inhibitors in NRAS and BRAF mutant melanoma.

被引：0
|
作者：
Malek, Shiva [1 ]
机构：
[1] Genentech Inc, San Francisco, CA USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
36
引用
收藏
页数：2
相关论文
共 50 条
  • [1] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma
    Ivana Yen
    Frances Shanahan
    Jeeyun Lee
    Yong Sang Hong
    Sang Joon Shin
    Amanda R. Moore
    Jawahar Sudhamsu
    Matthew T. Chang
    Inhwan Bae
    Darlene Dela Cruz
    Thomas Hunsaker
    Christiaan Klijn
    Nicholas P. D. Liau
    Eva Lin
    Scott E. Martin
    Zora Modrusan
    Robert Piskol
    Ehud Segal
    Avinashnarayan Venkatanarayan
    Xin Ye
    Jianping Yin
    Liangxuan Zhang
    Jin-Soo Kim
    Hyeong-Seok Lim
    Kyu-Pyo Kim
    Yu Jung Kim
    Hye Sook Han
    Soo Jung Lee
    Seung Tae Kim
    Minkyu Jung
    Yoon-hee Hong
    Young Su Noh
    Munjeong Choi
    Oakpil Han
    Malgorzata Nowicka
    Shrividhya Srinivasan
    Yibing Yan
    Tae Won Kim
    Shiva Malek
    Nature, 2021, 594 : 418 - 423
  • [2] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma
    Yen, Ivana
    Shanahan, Frances
    Lee, Jeeyun
    Hong, Yong Sang
    Shin, Sang Joon
    Moore, Amanda R.
    Sudhamsu, Jawahar
    Chang, Matthew T.
    Bae, Inhwan
    Dela Cruz, Darlene
    Hunsaker, Thomas
    Klijn, Christiaan
    Liau, Nicholas P. D.
    Lin, Eva
    Martin, Scott E.
    Modrusan, Zora
    Piskol, Robert
    Segal, Ehud
    Venkatanarayan, Avinashnarayan
    Ye, Xin
    Yin, Jianping
    Zhang, Liangxuan
    Kim, Jin-Soo
    Lim, Hyeong-Seok
    Kim, Kyu-Pyo
    Kim, Yu Jung
    Han, Hye Sook
    Lee, Soo Jung
    Kim, Seung Tae
    Jung, Minkyu
    Hong, Yoon-hee
    Noh, Young Su
    Choi, Munjeong
    Han, Oakpil
    Nowicka, Malgorzata
    Srinivasan, Shrividhya
    Yan, Yibing
    Kim, Tae Won
    Malek, Shiva
    NATURE, 2021, 594 (7863) : 418 - +
  • [3] RAF signaling and SHOC2 mediate mutant NRAS acquired resistance to RAF inhibitors in melanoma
    Kugel, Curtis H.
    CANCER RESEARCH, 2012, 72
  • [4] C-RAF Mutations Confer Resistance to RAF Inhibitors
    Antony, Rajee
    Emery, Caroline M.
    Sawyer, Allison M.
    Garraway, Levi A.
    CANCER RESEARCH, 2013, 73 (15) : 4840 - 4851
  • [5] ARAF MUTATIONS LIMIT RESPONSE TO RAF DIMER INHIBITION
    不详
    CANCER DISCOVERY, 2021, 11 (07) : 1610 - 1610
  • [6] Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
    Mohammad Atefi
    Bjoern Titz
    Earl Avramis
    Charles Ng
    Deborah JL Wong
    Amanda Lassen
    Michael Cerniglia
    Helena Escuin-Ordinas
    David Foulad
    Begonya Comin-Anduix
    Thomas G Graeber
    Antoni Ribas
    Molecular Cancer, 14
  • [7] Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
    Atefi, Mohammad
    Titz, Bjoern
    Avramis, Earl
    Ng, Charles
    Wong, Deborah J. L.
    Lassen, Amanda
    Cerniglia, Michael
    Escuin-Ordinas, Helena
    Foulad, David
    Comin-Anduix, Begonya
    Graeber, Thomas G.
    Ribas, Antoni
    MOLECULAR CANCER, 2015, 14
  • [8] Resistance to BRAF and MEK inhibitors in BRAF-mutant melanoma
    Patel, Hima
    Yacoub, Nour
    Garrett, Joan T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB43 - AB43
  • [9] Targeting different conformations of BRAF kinase: efficacy of Omni-Raf inhibitors in NRAS and BRAF mutant tumors
    Zhang, C.
    Cho, H.
    Spevak, W.
    Zhang, Y.
    Burton, B.
    Wong, B.
    Tsai, J.
    Ibrahim, P.
    Hirth, P.
    Bollag, G.
    EJC SUPPLEMENTS, 2010, 8 (07): : 46 - 46
  • [10] Using deep learning algorithms on histopathology images for the prediction of BRAF and NRAS mutations in invasive melanoma.
    Kim, Randie H.
    Nomikou, Sofia
    Dawood, Zarmeena
    Coudray, Nicolas
    Weber, Jeffrey S.
    Shapiro, Richard L.
    Berman, Russell S.
    Osman, Iman
    Tsirigos, Aristotelis
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345